Literature DB >> 24989435

Association between chronic hepatitis C virus infection and low muscle mass in US adults.

C Gowda1, C Compher, V K Amorosa, V Lo Re.   

Abstract

Given that low muscle mass can lead to worse health outcomes in patients with chronic infections, we assessed whether chronic hepatitis C virus (HCV) infection was associated with low muscle mass among US adults. We performed a cross-sectional study of the National Health Examination and Nutrition Study (1999-2010). Chronic HCV-infected patients had detectable HCV RNA. Low muscle mass was defined as <10th percentile for mid-upper arm circumference (MUAC). Multivariable logistic regression was used to determine adjusted odds ratios (aORs) with 95% confidence intervals (CIs) of low muscle mass associated with chronic HCV. Among 18 513 adults, chronic HCV-infected patients (n = 303) had a higher prevalence of low muscle mass than uninfected persons (13.8% vs 6.7%; aOR, 2.22; 95% CI, 1.39-3.56), and this association remained when analyses were repeated among persons without significant liver fibrosis (aOR, 2.12; 95% CI, 1.30-3.47). This study demonstrates that chronic HCV infection is associated with low muscle mass, as assessed by MUAC measurements, even in the absence of advanced liver disease.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  NHANES; chronic hepatitis C; low muscle mass; malnutrition

Mesh:

Substances:

Year:  2014        PMID: 24989435      PMCID: PMC4236264          DOI: 10.1111/jvh.12273

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  34 in total

Review 1.  The history of nutrition: malnutrition, infection and immunity.

Authors:  Gerald T Keusch
Journal:  J Nutr       Date:  2003-01       Impact factor: 4.798

2.  The predictive value of anthropometric parameters on mortality in haemodialysis patients.

Authors:  Milan Stosovic; Mirjana Stanojevic; Sanja Simic-Ogrizovic; Dijana Jovanovic; Ljubica Djukanovic
Journal:  Nephrol Dial Transplant       Date:  2010-08-16       Impact factor: 5.992

3.  Optimal nutritional indexes in chronic liver disease.

Authors:  M Merli; A Romiti; O Riggio; L Capocaccia
Journal:  JPEN J Parenter Enteral Nutr       Date:  1987 Sep-Oct       Impact factor: 4.016

4.  Nutrition and survival in patients with liver cirrhosis.

Authors:  F Alberino; A Gatta; P Amodio; C Merkel; L Di Pascoli; G Boffo; L Caregaro
Journal:  Nutrition       Date:  2001-06       Impact factor: 4.008

5.  Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index.

Authors:  Thomas B Kelleher; Shruti H Mehta; Ramakrishnan Bhaskar; Mark Sulkowski; Jacquie Astemborski; David L Thomas; Richard E Moore; Nezam H Afdhal
Journal:  J Hepatol       Date:  2005-04-25       Impact factor: 25.083

Review 6.  Prevalence and mechanisms of malnutrition in patients with advanced liver disease, and nutrition management strategies.

Authors:  Kally Cheung; Samuel S Lee; Maitreyi Raman
Journal:  Clin Gastroenterol Hepatol       Date:  2011-09-03       Impact factor: 11.382

Review 7.  Triple trouble: the role of malnutrition in tuberculosis and human immunodeficiency virus co-infection.

Authors:  Monique van Lettow; Wafaie W Fawzi; Richard D Semba
Journal:  Nutr Rev       Date:  2003-03       Impact factor: 7.110

Review 8.  The interaction between nutrition and infection.

Authors:  Peter Katona; Judit Katona-Apte
Journal:  Clin Infect Dis       Date:  2008-05-15       Impact factor: 9.079

Review 9.  Sarcopenia and age-related changes in body composition and functional capacity.

Authors:  W J Evans; W W Campbell
Journal:  J Nutr       Date:  1993-02       Impact factor: 4.798

10.  Assessment of simple risk markers for early mortality among HIV-infected patients in Guinea-Bissau: a cohort study.

Authors:  Inés Oliveira; Andreas Andersen; Alcino Furtado; Candida Medina; David da Silva; Zacarias J da Silva; Peter Aaby; Alex Lund Laursen; Christian Wejse; Jesper Eugen-Olsen
Journal:  BMJ Open       Date:  2012-11-14       Impact factor: 2.692

View more
  5 in total

1.  Prevalence and predictors of low muscle mass in HIV/viral hepatitis coinfection.

Authors:  Charitha Gowda; Todd T Brown; Charlene Compher; Kimberly A Forde; Jay Kostman; Pamela A Shaw; Phyllis C Tien; Vincent Lo Re
Journal:  AIDS       Date:  2016-10-23       Impact factor: 4.177

2.  Excess Weight Gain After Cure of Hepatitis C Infection with Direct-Acting Antivirals.

Authors:  Albert Do; Denise A Esserman; Supriya Krishnan; Joseph K Lim; Tamar H Taddei; Ronald G Hauser; Janet P Tate; Vincent Lo Re; Amy C Justice
Journal:  J Gen Intern Med       Date:  2020-04-27       Impact factor: 5.128

3.  Direct-acting Antivirals Improved the Quality of Life, Ameliorated Disease-related Symptoms, and Augmented Muscle Volume Three Years Later in Patients with Hepatitis C Virus.

Authors:  Tatsuki Ichikawa; Hisamitsu Miyaaki; Satoshi Miuma; Yasuhide Motoyoshi; Mio Yamashima; Shinobu Yamamichi; Makiko Koike; Yusuke Nakano; Tetsurou Honda; Hiroyuki Yajima; Ryouhei Uehara; Osamu Miyazaki; Yasutaka Kuribayashi; Keiji Kira; Naota Taura; Kazuhiko Nakao
Journal:  Intern Med       Date:  2020-11-01       Impact factor: 1.271

Review 4.  Metabolic aspects of hepatitis C virus.

Authors:  Mohamed El-Kassas; Abeer Awad
Journal:  World J Gastroenterol       Date:  2022-06-14       Impact factor: 5.374

5.  Association between pre-sarcopenia, sarcopenia, and bone mineral density in patients with chronic hepatitis C.

Authors:  Tatiana Bering; Kiara G D Diniz; Marta Paula P Coelho; Diego A Vieira; Maria Marta S Soares; Adriana M Kakehasi; Maria Isabel T D Correia; Rosângela Teixeira; Dulciene M M Queiroz; Gifone A Rocha; Luciana D Silva
Journal:  J Cachexia Sarcopenia Muscle       Date:  2018-01-19       Impact factor: 12.910

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.